Hysbysiad tryloywder gwirfoddol ymlaen llaw
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
Cardiff and Vale University Health Board
Woodland House, Maes Y Coed Road
Cardiff
CF144HH
UK
Ffôn: +44 2921501500
E-bost: sarah.yellen@wales.nhs.uk
NUTS: UK
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: http://nwssp.nhs.wales/ourservices/procurement-services/
Cyfeiriad proffil y prynwr: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
I.4) Y math o awdurdod contractio
Corff a lywodraethir gan gyfraith gyhoeddus
I.5) Prif weithgaredd
Iechyd
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
Managed Services Contract – Medical Biochemistry & Immunology
Cyfeirnod: CAV-DCO )24-25) 142 CR46
II.1.2) Prif god CPV
85111800
II.1.3) Y math o gontract
Gwasanaethau
II.1.4) Disgrifiad byr
Cardiff and Vale University Health Board (CVUHB) currently operate a Managed Service Contract with Abbot Diagnostics that covers Biochemistry and Immunology equipment , maintenance and related consumable.. This contract was awarded with commencement 1st April 2010 following an OJEU Competitive Dialogue procurement exercise for an initial term of 7 years to 31st March 2017, with the option to extend at the Health Boards discretion for a further 8 years until 31st March 2025, all extension options have been exhausted
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.1.7) Cyfanswm gwerth y caffaeliad
Gwerth heb gynnwys TAW: 51 100 135.28 GBP
II.2) Disgrifiad
II.2.3) Man cyflawni
Cod NUTS:
UKL
Prif safle neu fan cyflawni:
Cardiff and Vale University Health Board (CVUHB)
II.2.4) Disgrifiad o’r caffaeliad
The Health Board wish to apply a modification to the original contract award to add an additional 8 years on to the current contract under the same terms and conditions to extend the contract up to 31st March 2033. The modification will enable the Health Board to undertake an equipment refresh of critical equipment that will put the Health Board services at significant risk if not replaced urgently.
This modification is being made under PCR 2015 Regulation 72 (1) (b), to ensure that existing and planned replacement equipment supplied through the Managed Service Contract will provide the stability necessary to support strategic planning including the introduction of the Laboratory Information Management System.
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Na
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.1) Y math o weithdrefn
Dyfarnu contract heb gyhoeddi galwad am gystadleuaeth yng Nghyfnodolyn Swyddogol yr Undeb Ewropeaidd ymlaen llaw
Cyfiawnhau'r weithdrefn ddyfarnu a ddewiswyd:
Mae’r caffaeliad y tu allan i gwmpas cymhwysiad y gyfarwyddeb
Esboniad:
The Health Board wish to apply a modification to the original contract award to add an additional 8 years on to the current contract under the same terms and conditions to extend the contract up to 31st March 2033. The modification will enable the Health Board to undertake an equipment refresh of critical equipment that will put the Health Board services at significant risk if not replaced urgently.
This modification is being made under PCR 2015 Regulation 72 (1) (b), to ensure that existing and planned replacement equipment supplied through the Managed Service Contract will provide the stability necessary to support strategic planning including the introduction of the Laboratory Information Management System
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Ydy
Section V: Dyfarnu contract/consesiwn
Rhif Contract: CAV-DCO (24-25) 142 CR46
V.2 Dyfarnu contract/consesiwn
V.2.1) Y dyddiad y daeth y contract i ben/consesiwn
20/12/2024
V.2.2) Gwybodaeth am dendrau
Dyfarnwyd y contract i gr?p o weithredwyr economaidd:
Na
V.2.3) Enw a chyfeiriad y contractwr
Abbott Diagnostics
Vanwall Business Park
Maidenhead
SL64XE
UK
NUTS: UK
BBaCh yw’r contractwr:
Na
V.2.4) Gwybodaeth am werth y consesiwn a’r prif delerau cyllido (heb gynnwys TAW)
Cyfanswm gwerth y consesiwn/lot: 51 100 135.28 GBP
V.2.5) Gwybodaeth am is-gontractio
Mae’n debygol y /consesiwn caiff y contract ei is-gontractio
Y gwerth neu gyfran sy’n debygol o gael ei (h)is-gontractio i drydydd partïon
Gwerth heb gynnwys TAW: 22 302 975.28 GBP
Disgrifiad byr o’r rhan o’r contract i’w his-gontractio:
Third Party Spend related to the kit and consumables linked into this contract outside of Abbott
Section VI: Gwybodaeth ategol
VI.3) Gwybodaeth ychwanegol
N/A
(WA Ref:146932)
VI.4) Gweithdrefnau adolygu
VI.4.1) Corff adolygu
High Court
Royal Courts of Justice, The Strand
London
WC2A 2LL
UK
Ffôn: +44 2079477501
VI.5) Dyddiad anfon yr hysbysiad hwn
20/12/2024